CLINICAL_TRIALS
trial_result
· 2022-06-06
Clinical Trial Update: A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure [Phase 3]
Summary
A Phase 3 clinical trial evaluating the effect of empagliflozin in patients hospitalized for acute heart failure has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2022-06-06